Unknown NA INTERVENTIONAL 2-arm NCT05171582

Peri-implantitis Surgical Regenerative Therapy Using Bovine Bone Substitute With Hyaluronic Acid

The Effect of Periimplantitis Surgical Regenerative Therapy Using Bovine Bone Substitute With Hyaluronic Acid: Randomized Controlled Clinical Trials

Sponsor: Botiss Medical AG

Conditions Peri-Implantitis

Interventions Surgery 1 (Test group) Surgery 2 (Control group)

Updated 5 times since 2022 Last updated: Dec 26, 2021 Started: Apr 15, 2021 Primary completion: May 15, 2023 Completion: Nov 15, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05171582, this NA trial focuses on Peri-Implantitis and remains ongoing. Sponsored by Botiss Medical AG, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2024 — Jul 2024 [monthly]

Unknown Status NA
Jan 2024 — Feb 2024 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jan 2022 — Jan 2024 [monthly]

Active Not Recruiting NA

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Botiss Medical AG
Military Medical Academy, Bulgaria

Data source: Botiss Medical AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Belgrade, Serbia